What is the main business of Glatton?

The main business activity of Glatton focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 9, 2014.

Where is the headquarters located?

The headquarters is located at: ul. Majowa 20, 05-092 Łomianki.

Who is on the management board?

The management board consists of: Maciej Wieczorek (Member of the Management Board) and Urszula Wieczorek (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 400,005,000 (approx. $108.1 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What was the revenue?

The company reported a revenue of $1,086,294 in 2023, which is a decrease of 38.2% compared to 2022.

Yes, the company recorded a net profit of $354,394 in 2023, meaning the company decreased its profit by 71.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $158,403 in 2023, representing 80% of all operating expenses.

Glattonsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-09-09

Share capital

400,005,000.00 PLN

Registered address

ul. Majowa 20, 05-092 Łomianki, Poland

Website

glatton.pl

Electronic delivery address

AE:PL-71232-82470-UCREC-17

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 616 days for 2020).

2024not filed
202327/06/2024
202227/06/2024
202123/06/2023
202023/06/2023
201908/06/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 1.09mMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD 354.39kMedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 196.88kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 104.57mMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Maciej Wieczorek – Management Board Member

Urszula Wieczorek – Management Board Member

Manner of representation

A member of the management board acting independently is entitled to represent the company.

Ownership

Owner	Shares	Share value	Stake
Maciej Wieczorekage 57	8,000,100	$108,051,053.48	100%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Neitecsp. z o.o.	129,740.68 USD	61.3175%

Bank accounts

Registered as a VAT taxpayer on 2014-09-27.

Alior Bank
91 2490 0005 0000 4520 1173 0822

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
BiotonS.A.	$72,911,351.08	bioton.com
Celon PharmaS.A.	$52,550,739.16	celonpharma.com
VercoS.A.	$43,577,172.02	verco.com.pl
VipharmS.A.	$30,660,173.61	vipharm.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com

Change history

Date	Event
2025-10-21	Switch to PKD 2025 (7 PKD 2007 codes → 6 PKD 2025 codes)
2015-06-15	Share capital increase (5,000.00 PLN → 400,005,000.00 PLN)
2015-05-19	Address change (Wybrzeże Kościuszkowskie 43/2, 00-347, Warszawa → Ul. Majowa 20, 05-092, Łomianki)
2015-03-05	PKD change (Removed: 78 codes; Added: 10 codes)
2014-09-09	Entered in the register

FAQ

Last updated: 2026-10-07